Previous research has shown findings of higher baseline muscle activation and abnormal EMG as a response to stress in chronic back pain patients.

There are various aims biofeedback can target, e.g., developing more awareness or control for physiological processes and thus, consciously reducing muscle tension.

Biofeedback instruments measure physiological activity such as brainwaves, heart function, breathing, muscle activity, and skin temperature and rapidly and accurately provide feedback information to the user. Condition or diseaseĬhronic Low-back Pain Mastectomy Lumpectomy Migraineĭevice: JOGO Digital Therapeutics EMG Biofeedback for Lower Back Pain Device: JOGO Digital Therapeutics EMG Biofeedback for Persistent Post Mastectomy Pain Device: JOGO Digital Therapeutics EMG Biofeedback for Migraineīiofeedback can be described as 'operant conditioning of physiological activity', by which 'the patient learns to self-regulate his or her physiological processes with the help of feedback information', and can comprise different sites, modalities, and procedures. We hypothesize that patients that will undergo the EMG-BF will demonstrate reductions in pain, physical functioning, sleep, pain catastrophizing, anxiety and depression. The aims of this study are to examine the impact of EMG-BF on pain and QST and the impact of EMG-BF on psychosocial function. Patients in the control group will undergo sensory testing procedures at baseline and after treatment period but will receive no active treatment. The intervention consists of weekly sessions during which participants will be instructed on how to use the device by a trained biofeedback instructor. Patients assigned to the intervention group will be asked to complete self-report questionnaires assessing demographics, pain intensity, negative affect, physical function, pain catastrophizing and sleep, will undergo QST and will be asked to wear Actiwatches to keep track of health behaviors, prior to and after completing the intervention. Participants will be randomly assigned to either the JOGO Digital Therapeutics EMG Biofeedback device or treatment as usual control group. The purpose of this pilot efficacy study is to examine the effects of EMG-biofeedback (EMG-BF) on pain-related outcomes in Chronic Low Back Pain (CLBP) patients, Recent mastectomy and lumpectomy patients, and patients with episodic migraine.ĮMG-BF facilitates neuromuscular retraining and muscle relaxation by using audio and visual stimuli using an EMG surface electrode-based biosensor and a software installed on a tablet or smart phone.įor this pilot efficacy study, we will recruit 125 patients with chronic low back pain, 125 patients who are expected to undergo mastectomy and 80 patients with episodic migraine.

Why Should I Register and Submit Results?.

Emg back